Physician profile
Paul E Caldwell
NPI 1457304784
$146,708.40
in general payments reported to CMS, 2019-2025
14 companies · $27K in 2025
The $27K reported for 2025 was more than what 92% of Sports Medicine (Orthopaedic Surgery) providers received nationally (typical 2025 total: $686).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $11K · 2020: $13K · 2021: $44K · 2022: $21K · 2023: $18K · 2024: $13K · 2025: $27K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $41K · Travel and Lodging: $11K · Consulting Fee: $2,800 · Food and Beverage: $2,577.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $41,115.35 |
| Travel and Lodging | $11,333.47 |
| Consulting Fee | $2,800.00 |
| Food and Beverage | $2,577.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $118,982.06 | 2019-2025 | |
| Joint Restoration Foundation, INC. | $12,100.00 | 2019-2023 | |
| Vericel Corporation | $7,479.91 | 2019-2025 | Maci |
| Fortis Surgical, LLC | $6,052.68 | 2019-2025 | |
| Geistlich Pharma, North America, INC. | $750.00 | 2022 | |
| Horizon Therapeutics Plc | $613.42 | 2019-2022 | |
| Aesculap Biologics, LLC | $286.62 | 2019 | |
| Depuy Synthes Sales INC. | $151.35 | 2020-2024 | Monovisc |
| Linvatec Corporation | $79.54 | 2019 | |
| Pacira Therapeutics, INC. | $74.16 | 2019 | |
| Smith+Nephew, INC. | $49.19 | 2023-2024 | Microraptor, Q-Fix, N/A |
| Vertex Pharmaceuticals Incorporated | $44.31 | 2024-2025 | |
| Pacira Pharmaceuticals Incorporated | $31.53 | 2019-2022 | |
| Stryker Corporation | $13.63 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Paul Caldwell listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.